Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALGB 9633: Adjuvant Paclitaxel/Carboplatin in Stage IB NSCLC
NCT00002852Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 1996
- Primary completion
- Jul 2004
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, carboplatin in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Oct 1996; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00002852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002852.